Tops & Flops Stocks
Security | Change (%) | 1w | 1m | 1y ▼ | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Corvus Pharmaceuticals Inc | 2.860% | -4.985% | -23.293% | 33.830% | -17.237% | -45.304% | -65.899% |
Ardelyx Inc. | 0.540% | -5.482% | -15.972% | 32.578% | 3.218% | -12.905% | - |
Innoviva Inc. | 2.140% | 2.899% | 2.899% | 30.275% | -2.740% | 46.392% | - |
Glycomimetics Inc. | 6.770% | -15.567% | -37.101% | 30.243% | -24.159% | -18.381% | - |
Otsuka Holdings Co. Ltd. | - | -0.526% | -3.077% | 26.846% | 13.855% | 16.667% | 22.350% |
Exelixis Inc. | 1.060% | 1.540% | -1.091% | 25.780% | -0.548% | 6.043% | 19.877% |
Ose Pharma International S.A. | -2.340% | 20.808% | 24.066% | 25.762% | 36.686% | - | - |
Virbac S.A. | -3.260% | 3.949% | 8.382% | 25.554% | 2.646% | 31.373% | 141.165% |
Vertex Pharmaceuticals Inc. | -1.190% | 1.927% | -2.021% | 25.544% | 1.762% | 109.994% | 141.569% |
Inventiva SA | -1.730% | -0.319% | -10.842% | 25.000% | -23.501% | -71.330% | - |
IQVIA Holdings Inc. | 1.290% | 3.336% | -4.497% | 23.068% | 6.444% | 18.522% | - |
Intra-Cellular Therapies Inc. | -1.440% | -7.947% | 8.764% | 22.575% | 6.595% | 174.270% | 569.170% |
Santen Pharmaceutical Corp Ltd. | 2.840% | 1.149% | -1.124% | 22.222% | -1.124% | -20.000% | -34.102% |
Viatris Inc. | 0.280% | 1.386% | -3.052% | 20.884% | 8.798% | -3.947% | -55.792% |
Knight Therapeutics | - | 0.000% | 9.551% | 20.370% | 10.795% | 5.978% | -16.827% |